http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EA-201070055-A1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-24 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C291-04 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-24 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C291-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-135 |
| filingDate | 2008-06-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2010-06-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | EA-201070055-A1 |
| titleOfInvention | N-OXIDES OF VENLAFAXIN AND O-DESMETHYL VENLAFAXIN AS PROCEDURES |
| abstract | This invention relates to venlafaxine N-oxide and O-desmethyl venlafaxine N-oxide as prodrugs of venlafaxine and its main (active) metabolite O-desmethyl venlafaxine, respectively, to pharmaceutical compositions containing these N-oxides, to methods for their preparation and methods for their preparation compositions. This invention relates to an N-oxide having the formula (1), in which R represents H or CH, and its tautomers, stereoisomers, hydrates and solvates. This invention also relates to the use of N-oxides and compositions, especially for the manufacture of drugs used to treat affective processes or diseases that are effective in treating, albeit with side effects, venlafaxine. |
| priorityDate | 2007-06-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 17.